Cost-Benefit Assessment of the Electronic Health Records for Clinical Research (EHR4CR) European Project
Value Health
.
2014 Nov;17(7):A630.
doi: 10.1016/j.jval.2014.08.2251.
Epub 2014 Oct 26.
Authors
A Beresniak
1
,
A Schmidt
2
,
J Proeve
3
,
E Bolanos
4
,
N Patel
5
,
N Ammour
6
,
M Sundgren
7
,
M Ericson
8
,
G De Moor
9
,
D Kalra
10
,
D Dupont
1
Affiliations
1
Data Mining International, Geneva, Switzerland.
2
F Hoffmann-La Roche Ltd, Basel, Switzerland.
3
Bayer Healthcare, Leverkusen, Germany.
4
Eli Lilly and Company, Alcobendas, Spain.
5
Eli Lilly and Company (until December 2013), Windlesham, Surrey, UK.
6
Sanofi-Aventis R&D, Chilly-Mazarin, France.
7
AstraZeneca, Mölndal, Sweden.
8
Amgen, Neuilly-sur-Seine, France.
9
University of Ghent, Ghent, Belgium.
10
The European Institute for Health Records (EuroRec), London, UK.
PMID:
27202235
DOI:
10.1016/j.jval.2014.08.2251
No abstract available